The Library
Browse by Warwick Author
Up a level |
Number of items: 68.
Afshar, Mehran, Patel, Hiten R. H., Jain, Ankit, Kumar, Abhishek, Patel, Prashant, James, Nicholas D. and Porfiri, Emilio (2019) Chronic tyrosine kinase inhibitor (TKI) use in metastatic renal cell carcinoma (mRCC) : can this lead to the adverse effect of hypogonadism? Expert Review of Anticancer Therapy, 19 (6). pp. 529-532. doi:10.1080/14737140.2019.1609355 ISSN 1473-7140.
Afshar, Mehran, Goodfellow, Henry, Jackson-Spence, Francesca, Evison, Felicity, Parkin, John, Bryan, Richard T., Parsons, Helen, James, Nicholas D. and Patel, Prashant (2018) Centralisation of radical cystectomies for bladder cancer in England, a decade on from the 'Improving Outcomes Guidance' : the case for super centralisation. BJU International, 121 (2). pp. 217-224. doi:10.1111/bju.13929 ISSN 1464-1603.
Feber, Andrew, Dhami, Pawan, Dong, Liqin, de Winter, Patricia, Tan, Wei Shen, MartΓnez-FernΓ‘ndez, MΓ³nica, Paul, Dirk S., Hynes-Allen, Antony, Rezaee, Sheida, Gurung, Pratik et al.
(2017)
UroMarkβa urinary biomarker assay for the detection of bladder cancer.
Clinical Epigenetics, 9
(1).
8.
doi:10.1186/s13148-016-0303-5
ISSN 1868-7075.
Andronis, L. (Lazaros) , Billingham, Lucinda J., Bryan, Stirling, James, Nicholas D. and Barton, Pelham (2016) A practical application of value of information and prospective payback of research to prioritize evaluative research. Medical Decision Making, 36 (3). pp. 321-334. doi:10.1177/0272989X15594369 ISSN 0272-989X.
James, Nicholas D., Pirrie, Sarah J., Pope, Ann M., Barton, Darren, Andronis, Lazaros, Goranitis, Ilias, Collins, Stuart, Daunton, Adam, McLaren, Duncan, OβSullivan, Joe et al.
(2016)
Clinical outcomes and survival following treatment of metastatic castrate-refractory prostate cancer with docetaxel alone or with strontium-89, zoledronic acid, or both.
JAMA Oncology, 2
(4).
pp. 493-499.
doi:10.1001/jamaoncol.2015.5570
ISSN 2374-2437.
James, Nicholas D., Spears, Melissa R., Clarke, Noel W., Dearnaley, David P., Mason, Malcolm D., Parker, Christopher C., Ritchie, Alastair W. S., Russell, J. Martin, Schiavone, Francesca, Attard, Gerhardt et al.
(2016)
Failure-free survival and radiotherapy in patients with newly diagnosed nonmetastatic prostate cancer.
JAMA Oncology, 2
(3).
pp. 348-357.
doi:10.1001/jamaoncol.2015.4350
ISSN 2374-2437.
Real, Francisco X., Ward, Douglas G., Baxter, Laura, Gordon, Naheema S., Ott, Sascha, Savage, Richard S., Beggs, Andrew D., James, Jonathan D., Lickiss, Jennifer, Green, Shaun, Wallis, Yvonne, Wei, Wenbin, James, Nicholas D., Zeegers, Maurice P., Cheng, K. K., Mathews, Glenn M., Patel, Prashant, Griffiths, Michael and Bryan, Richard T. (2016) Multiplex PCR and next generation sequencing for the non-invasive detection of bladder cancer. PLoS One, 11 (2). pp. 1-11. e0149756. doi:10.1371/journal.pone.0149756 ISSN 1932-6203.
Vale, Claire L., Burdett, Sarah, Rydzewska, Larysa H. M., Albiges, Laurence, Clarke, Noel W., Fisher, David, Fizazi, Karim, Gravis, Gwenaelle, James, Nicholas D., Mason, Malcolm D., Parmar, Mahesh K. B., Sweeney, Christopher J., Sydes, Matthew R., Tombal, Bertrand and Tierney, Jayne F. (2016) Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer : a systematic review and meta-analyses of aggregate data. The Lancet Oncology, 17 (2). pp. 243-256. doi:10.1016/S1470-2045(15)00489-1 ISSN 1470-2045.
Bahl, Amit, Masson, Susan, Malik, Zafar, Birtle, Alison J., Sundar, Santhanam, Jones, Rob J., James, Nicholas D., Mason, Malcolm D., Kumar, Satish, Bottomley, David, Lydon, Anna, Chowdhury, Simon, Wylie, James and de Bono, Johann S. (2015) Final quality of life and safety data for patients with metastatic castration-resistant prostate cancer treated with cabazitaxel in the UK Early Access Programme (EAP) (NCT01254279). BJU International, 116 (6). pp. 880-887. doi:10.1111/bju.13069 ISSN 1464-1603.
Kitchen, Mark O., Bryan, Richard T., Haworth, Kim E., Emes, Richard D., Luscombe, Christopher, Gommersall, Lyndon, Cheng, Kar K., Zeegers, Maurice P., James, Nicholas D., Devall, Adam J., Fryer, Anthony A. and Farrell, William E. (2015) Methylation of HOXA9 and ISL1 predicts patient outcome in high-grade non-invasive bladder cancer. PLoS One, 10 (9). pp. 1-12. e0137003. doi:10.1371/journal.pone.0137003 ISSN 1932-6203.
Bryan, R. T., Evans, T., Dunn, Janet A., Iqbal, Gulnaz, Bathers, S., Collins, S. I., James, Nicholas D., Catto, J. W. F. and Wallace, D. M. A. (2015) A comparative analysis of the influence of gender, pathway delays, and risk factor exposures on the long-term outcomes of bladder cancer. European Urology Focus, 1 (1). pp. 82-89. doi:10.1016/j.euf.2015.01.001 ISSN 2405-4569.
Afshar, Mehran, Evison, Felicity, James, Nicholas D. and Patel, Prashant (2015) Shifting paradigms in the estimation of survival for castration-resistant prostate cancer : A tertiary academic center experience. Urologic Oncology: Seminars and Original Investigations, 33 (8). 338.e1-338.e7. doi:10.1016/j.urolonc.2015.05.003 ISSN 1078-1439.
Gillessen, S., Omlin, A., Attard, G., de Bono, Johann S., Efstathiou, E., Fizazi, K., Halabi, S., Nelson, P. S., Sartor, O., Smith, M. R. et al.
(2015)
Management of patients with advanced prostate cancer : recommendations of the St. Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
Annals of Oncology, 26
(8).
pp. 1589-1604.
doi:10.1093/annonc/mdv257
ISSN 0923-7534.
Fizazi, Karim, Abrahamsson, Per-Anders, Ahlgren, Goran, Bellmunt, Joaquim, Castellano, Daniel, Culine, Stephane, de Wit, Ronald, Gillessen, Silke, Gschwend, Juergen E., Hamdy, Freddie, James, Nicholas D., McDermott, Raymond, Miller, Kurt, Wiegel, Thomas, Wirth, Manfred and Tombal, Bertrand (2015) Achievements and perspectives in prostate cancer phase 3 trials from genitourinary research groups in Europe : introducing the prostate cancer consortium in Europe. European Urology, 67 (5). pp. 904-912. doi:10.1016/j.eururo.2014.08.076 ISSN 0302-2838.
James, Nicholas D., Sydes, Matthew R., Clarke, Noel W., Mason, Malcolm D., Dearnaley, David P. and Spears, Melissa R. (2015) Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE) : survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. The Lancet, 387 (10024). pp. 1163-1177. doi:10.1016/S0140-6736(15)01037-5 ISSN 0140-6736.
Bryan, Richard T., Regan, H. L., Pirrie, S. J., Devall, A. J., Cheng, Kar K. , Zeegers, Maurice P., James, Nicholas D., Knowles, M. A. and Ward, D. G. (2015) Protein shedding in urothelial bladder cancer : prognostic implications of soluble urinary EGFR and EpCAM. British Journal of Cancer, 112 (6). pp. 1052-1058. doi:10.1038/bjc.2015.21 ISSN 0007-0920.
Afshar, Mehran, Al-Alloosh , F., Pirrie, S., Rowan, C., James, Nicholas D. and Porfiri, E. (2015) Predictive factors for response to abiraterone in metastatic castration refractory prostate cancer. Anticancer Research, 35 (2). pp. 1057-1063. ISSN 0250-7005.
McDonald, F., Waters, R., Gulliford, S., Hall, E., James, Nicholas D. and Huddart, R. A. (2015) Defining bowel dose volume constraints for bladder radiotherapy treatment planning. Clinical Oncology, Volume 27 (Number 1). pp. 22-29. doi:10.1016/j.clon.2014.09.016 ISSN 0936-6555.
Afshar, Mehran, Pascoe, Jennifer, Whitmarsh, Sue, James, Nicholas D. and Porfiri, Emilio (2014) Temsirolimus for patients with metastatic renal cell carcinoma : outcomes in patients receiving temsirolimus within a compassionate use program in a tertiary referral center. Drug Design, Development and Therapy, Volume 2015 (Number 9). pp. 13-19. doi:10.2147/DDDT.S73686 ISSN 1177-8881.
Attard, Gerhardt, Sydes, Matthew R., Mason, Malcolm D., Clarke, Noel W., Aebersold, Daniel, de Bono, Johann S., Dearnaley, David P., Parker, Chris C., Ritchie, Alastair W. S., Russell, J. Martin, Thalmann, George, Cassoly, Estelle, Millman, Robin, Matheson, David, Schiavone, Francesca, Spears, Melissa R., Parmar, Mahesh K. B. and James, Nicholas D. (2014) Combining enzalutamide with abiraterone, prednisone, and androgen deprivation therapy in the STAMPEDE trial. European Urology, 66 (5). pp. 799-802. 4. doi:10.1016/j.eururo.2014.05.038 ISSN 0302-2838.
James, Nicholas D., Spears, Melissa R., Clarke, Noel W., Dearnaley, David P., De Bono, Johann S., Gale, Joanna, Hetherington, John, Hoskin, Peter J., Jones, Robert J., Laing, Robert et al.
(2014)
Survival with newly diagnosed metastatic prostate cancer in the βDocetaxel eraβ : data from 917 patients in the control arm of the STAMPEDE trial (MRC PR08, CRUK/06/019).
European Urology, 67
(6).
pp. 1028-1038.
doi:10.1016/j.eururo.2014.09.032
ISSN 0302-2838.
Loriot, Yohann, Fizazi, Karim, Jones, Robert J., Van den Brande, Jan, Molife, Rhoda L., Omlin, Aurelius, James, Nicholas D., Baskin-Bey, Edwina, Heeringa, Marten, Baron, Benoit, Holtkamp, Gertjan M., Ouatas, Taoufik and De Bono, Johann S. (2014) Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with metastatic castration-resistant prostate cancer : multi-centre phase I/II study. Investigational New Drugs, 32 (5). pp. 995-1004. doi:10.1007/s10637-014-0101-x ISSN 0167-6997.
Slater, S. E., Patel, P., Viney, R., Foster, M., Porfiri, E., James, Nicholas D., Montgomery, B. and Bryan, Richard T. (2014) The effects and effectiveness of electromotive drug administration and chemohyperthermia for treating non-muscle invasive bladder cancer. The Annals of The Royal College of Surgeons of England, 96 (6). pp. 415-419. doi:10.1308/003588414X13946184901001 ISSN 0035-8843.
Fizazi, Karim, Massard, Christophe, Bono, Petri, Jones, Robert, Kataja, Vesa, James, Nicholas D., Garcia, Jorge M., Protheroe, Andrew, Tammela, Teuvo L. J., Elliott, Tony, Mattila, Leena, Aspegren, John, Vuorela, Annamari, Langmuir, Peter and Mustonen, Mika (2014) Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES) : an open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial. The Lancet Oncology, 15 (9). pp. 975-985. doi:10.1016/S1470-2045(14)70240-2 ISSN 1470-2045.
James, Nicholas D., Spears, Melissa R., Clarke, Noel W., Sydes, Matthew R., Parker, Christopher C., Dearnaley, David P., Russell, J. Martin, Ritchie, Alastair W. S., Thalmann, George, de Bono, Johann S., Attard, G., Amos, C., Parmar, Mahesh K. B. and Mason, Malcolm D. (2014) Impact of node status and radiotherapy on failure-free survival in patients with newly-diagnosed non-metastatic prostate cancer : data from > 690 patients in the control arm of the STAMPEDE Trial. Annals of Oncology, Volume 25 (Supplement 4). iv255-iv279. doi:10.1093/annonc/mdu336 ISSN 0923-7534.
Liu, Xiaoxuan, Dowell, Alexander C, Patel, Prashant, Viney, Richard P, Foster, Michael C, Porfiri, Emilio, James, Nicholas D. and Bryan, Richard T (2014) Cytokines as effectors and predictors of responses in the treatment of bladder cancer by bacillus CalmetteβGuΓ©rin. Future Oncology, 10 (8). pp. 1443-1456. doi:10.2217/fon.14.79 ISSN 1479-6694.
Ploussard, Guillaume, Daneshmand, Siamak, Efstathiou, Jason A., Herr, Harry W., James, Nicholas D., RΓΆdel, Claus M., Shariat, Shahrokh F., Shipley, William U., Sternberg, Cora N., Thalmann, George N. and Kassouf, Wassim (2014) Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer : a systematic review. European Urology, 66 (1). pp. 120-137. doi:10.1016/j.eururo.2014.02.038 ISSN 0302-2838.
Sartor, Oliver, Coleman, Robert, Nilsson, Sten, Heinrich, Daniel, Helle, Svein I., O'Sullivan, Joe M., FossΓ₯, Sophie D., Chodacki, AleΕ‘, Wiechno, PaweΕ, Logue, John et al.
(2014)
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases : results from a phase 3, double-blind, randomised trial.
The Lancet Oncology, Volume 15
(Number 7).
pp. 738-746.
doi:10.1016/S1470-2045(14)70183-4
ISSN 1470-2045.
Bryan, Richard T., Cheng, K. K. , James, Nicholas D., Zeegers, Maurice P. and Wallace, D. M. A. (2014) Re : defining progression in nonmuscle invasive bladder cancer : it is time for a new, standard definition. The Journal of Urology, 191 (6). pp. 1930-1931. doi:10.1016/j.juro.2014.01.011 ISSN 0022-5347.
Pond, Gregory R., Agarwal, Neeraj, Bellmunt, Joaquim, Choueiri, Toni K., Qu, Angela, Fougeray, Ronan, Vaughn, David, James, Nicholas D., Salhi, Yacine, Albers, Peter et al.
(2014)
A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma.
BJU International, 113
(5b).
E137-E143.
doi:10.1111/bju.12564
ISSN 1464-1603.
Bryan, Richard T., Shimwell, N. J., Wei, W., Devall, A. J., Pirrie, Anne, James, Nicholas D., Zeegers, Maurice P., Cheng, Kar K., Martin, A. and Ward, D. G. (2014) Urinary EpCAM in urothelial bladder cancer patients : characterisation and evaluation of biomarker potential. British Journal of Cancer, 110 (3). pp. 679-685. doi:10.1038/bjc.2013.744 ISSN 0007-0920.
Tombal, B., Alcaraz, Antonio, James, Nicholas D., Valdagni, R. and Irani, J. (2014) Can we improve the definition of high-risk, hormone naive, non-metastatic prostate cancer? BJU International, 113 (2). pp. 189-199. doi:10.1111/bju.12469 ISSN 1464-1603.
Huddart, Robert A., Hall, E., Hussain, S. A., Jenkins, P., Rawlings, C. J., Tremlett, J., Crundwell, M., Adab, F., Sheehan, D., Syndikus, Isabel, Hendron, C., Lewis, R., Waters, R. and James, Nicholas D. (2013) A randomized non-inferiority trial of reduced high dose volume versus standard volume radiotherapy for muscle-invasive bladder cancer : results of the BC2001 trial (CRUK/01/004). International Journal of Radiation : Oncology - Biology - Physics, 87 (2). pp. 261-269. doi:10.1016/j.ijrobp.2013.06.2044 ISSN 0360-3016.
James, Nicholas D. (2013) Best palliation in advanced cancer is often achieved by treating the cancer. BMJ, 347 (7915). p. 1. f4648. doi:10.1136/bmj.f4648 ISSN 0959-535X.
Parker, C., Nilsson, S., Heinrich, Daniel, Helle, Svein I., O'Sullivan, J. M., FossΓ₯, Sophie D., Chodacki, AleΕ‘, Wiechno, PaweΕ, Logue, John, Seke, M. et al.
(2013)
Alpha emitter radium-223 and survival in metastatic prostate cancer.
The New England Journal of Medicine, 369
(3).
pp. 213-223.
doi:10.1056/NEJMoa1213755
ISSN 0028-4793.
van Roekel, Eline H., Cheng, Kar K., James, Nicholas D., Wallace, D. Michael, Billingham, Lucinda J., Murray, Paul G., Bryan, Richard T. and Zeegers, Maurice P. (2013) Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumours at diagnosis. International Journal of Cancer, 133 (2). pp. 446-454. doi:10.1002/ijc.28017 ISSN 0020-7136.
Bryan, Richard T., Zeegers, Maurice P., van Roekel, Eline H., Bird, Deborah, Grant, Margaret R., Dunn, Janet A., Bathers, Sarah, Iqbal, Gulnaz, Khan, Humera S., Collins, Stuart I., Howman, Andrew, Deshmukh, Nayneeta S., James, Nicholas D., Cheng, Kar Keung and Wallace, D. Michael A. (2013) A comparison of patient and tumour characteristics in two UK bladder cancer cohorts separated by 20 years. BJU International, Volume 112 (Number 2). pp. 169-175. doi:10.1111/bju.12032 ISSN 1464-4096.
Morgan, Richard, Bryan, Richard T., Javed, Saqib, Launchberry, Francesca, Zeegers, Maurice, Cheng, Kar K. , James, Nicholas D., Wallace, Michael A., Hurst, Carolyn D., Ward, Douglas G., Knowles, Margaret A. and Pandha, Hardev (2013) Expression of engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker. European Journal of Cancer, 49 (9). pp. 2214-2222. doi:10.1016/j.ejca.2013.01.019 ISSN 0959-8049.
Parker, Christopher C., Sydes, Matthew R., Mason, Malcolm D., Clarke, Noel W., Aebersold, Daniel, De Bono, Johann S., Dearnaley, David P., Ritchie, A. W. S., Russell, J. Martin, Thalmann, George, Parmar, Mahesh K. B. and James, Nicholas D. (2013) Prostate radiotherapy for men with metastatic disease : a new comparison in the systemic therapy in advancing or metastatic prostate cancer : evaluation of drug efficacy (STAMPEDE) trial. BJU International, 111 (5). pp. 697-699. doi:10.1111/bju.12087 ISSN 1464-1603.
Sonpavde, Guru, Pond, Gregory R., Fougeray, Ronan, Choueiri, Toni K. , Qu, Angela, Vaughn, David, Niegisch, GΓΌnter, Albers, Peter, James, Nicholas D., Wong, Yu-Ning et al.
(2013)
Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma : a retrospective analysis of pooled, prospective phase 2 trials.
European Urology, 63
(4).
pp. 717-723.
doi:10.1016/j.eururo.2012.11.042
ISSN 0302-2838.
James, Nicholas D., Sydes, Matthew R., Mason, Malcolm D., Clarke, Noel W., Anderson, John, Dearnaley, David P., Dwyer, John, Jovic, Gordana, Ritchie, Alastair W. S., Russell, J. Martin, Sanders, Karen, Thalmann, George N., Bertelli, Gianfilippo, Birtle, Alison J., O'Sullivan, Joe M., Protheroe, Andrew, Sheehan, Denise, Srihari, Narayanan and Parmar, Mahesh K. B. (2012) Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer : first results from the STAMPEDE multiarm, multistage, randomised controlled trial. The Lancet Oncology, 13 (5). pp. 549-558. doi:10.1016/S1470-2045(12)70088-8 ISSN 1470-2045.
Sydes, Matthew R., James, Nicholas D., Mason, Malcolm D., Clarke, Noel W., Amos, Claire, Anderson, John, de Bono, Johann S., Dearnaley, David P, Dwyer, John, Jovic, Gordana, Ritchie, Alastair W. S., Russell, Martin, Sanders, Karen, Thalmann, George and Parmar, Mahesh K. B. (2012) Flexible trial design in practice β dropping and adding arms in STAMPEDE : a multi-arm multi-stage randomised controlled trial. Trials, 12 (Supplement 1). A3. doi:10.1186/1745-6215-12-S1-A3 ISSN 1745-6215.
James, Nicholas D., Hussain, Syed A., Hall, Emma, Jenkins, Peter, Tremlett, Jean, Rawlings, Christine, Crundwell, Malcolm, Sizer, Bruce, Sreenivasan, Thiagarajan, Hendron, Carey, Lewis, Rebecca, Waters, Rachel and Huddart, Robert A. (2012) Radiotherapy with or without Chemotherapy in muscle-invasive bladder cancer. New England Journal Of Medicine , 366 (16). pp. 1477-1488. doi:10.1056/NEJMoa1106106 ISSN 0028-4793.
Hussain, S. A., Palmer, D. H., Lloyd, B., Collins, S. I., Barton, D., Ansari, J. and James, Nicholas D. (2012) A study of split-dose cisplatin-based neo-adjuvant chemotherapy in muscle-invasive bladder cancer. Oncology Letters, 3 (4). pp. 855-859. doi:10.3892/ol.2012.563 ISSN 1792-1074.
James, Nicholas D. (2011) Cancer : a very short introduction. Very Short Introductions . Oxford ; New York: Oxford University Press. ISBN 9780199560233
Brown, Janet E., Sherriff, Jennifer M. and James, Nicholas D. (2010) Osteoporosis in patients with prostate cancer on long-term androgen deprivation therapy : an increasing, but under-recognized problem. BJU International, 105 (8). pp. 1042-1043. doi:10.1111/j.1464-410X.2010.09251.x ISSN 1464-1603.
Gore, Martin E., Griffin, Clare L., Hancock, Barry, Patel, Poulam M., Pyle, Lynda, Aitchison, Michael, James, Nicholas D., Oliver, Roderick T. D., Mardiak, Jozef, Hussain, Tahera, Sylvester, Richard, Parmar, Mahesh K. B., Royston, Patrick and Mulders, Peter F. A. (2010) Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012) : an open-label randomised trial. The Lancet, 375 (9715). pp. 641-648. doi:10.1016/S0140-6736(09)61921-8 ISSN 0140-6736.
Sherriff, J. M., Brown, J. E. and James, Nicholas D. (2010) An under-recognised risk. BMJ, 340 (jan13 3). c143-c143. ISSN 0959-535X doi:10.1136/bmj.c143
Bryan, Richard T., Zeegers, Maurice P., James, Nicholas D., Wallace, D. Michael A. and Cheng, Kar Keung (2010) Biomarkers in bladder cancer. BJU International, 105 (5). pp. 608-613. doi:10.1111/j.1464-410X.2009.08880.x ISSN 1464-1603.
James, Nicholas D., Caty, Armelle, Payne, Heather, Borre, Michael, Zonnenberg, Bernard A., Beuzeboc, Philippe, McIntosh, Stuart, Morris, Thomas, Phung, De and Dawson, Nancy A. (2010) Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind, placebo-controlled, randomized Phase II trial. BJU International, 106 (7). pp. 966-973. doi:10.1111/j.1464-410X.2010.09638.x ISSN 1464-1603.
Dawson, Nancy, Payne, Heather, Battersby, Clare, Taboada, Maria and James, Nicholas D. (2010) Health-related quality of life in pain-free or mildly symptomatic patients with metastatic hormone-resistant prostate cancer following treatment with the specific endothelin A receptor antagonist zibotentan (ZD4054). Journal of Cancer Research and Clinical Oncology, 137 (1). pp. 99-113. doi:10.1007/s00432-010-0864-1 ISSN 0171-5216.
Zeegers, Maurice P., Bryan, Richard T., Langford, Carolyn, Billingham, Lucinda, Murray, Paul, Deshmukh, Neeta S., Hussain, Syed, James, Nicholas D., Wallace, D. Michael A. and Cheng, K.K. (2010) The West Midlands bladder cancer prognosis programme : rationale and design. BJU International, 105 (6). pp. 784-788. doi:10.1111/j.1464-410X.2009.08849.x ISSN 1464-1603.
Rossi, J-F., NΓ©grier, S., James, Nicholas D., Kocak, I., Hawkins, R., Davis, H., Prabhakar, U., Qin, X., Mulders, P. and Berns, B. (2010) A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer. British Journal of Cancer, 103 (8). pp. 1154-1162. doi:10.1038/sj.bjc.6605872 ISSN 0007-0920.
Patel, Prashant, Young, J Graham, Mautner, Vivien, Ashdown, Daniel, Bonney, Sarah, Pineda, Robert G., Collins, Stuart I., Searle, Peter F., Hull, Diana, Peers, Elizabeth, Chester, John, Wallace, D. Michael, Doherty, Alan, Leung, Hing, Young, Lawrence S. and James, Nicholas D. (2009) A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1984. Molecular Therapy, Vol.17 (No.7). pp. 1292-1299. doi:10.1038/mt.2009.80 ISSN 1525-0016.
Onion, David, Patel, Prashant, Pineda, Robert G., James, Nicholas D. and Mautner, Vivien (2009) Antivector and tumor immune responses following adenovirus-directed enzyme prodrug therapy for the treatment of prostate cancer. Human Gene Therapy, 20 (11). pp. 1249-1258. doi:10.1089/hum.2009.078 ISSN 1043-0342.
James, Nicholas D., Pascoe, J., Zachariah, A., Ray, D., Oldroyd, A., Parry, H., Benghiat, H., Karina, M., Collins, S. and Porfiri, E. (2009) Effect of the UK postcode lottery on survival of patients with metastatic renal cancer : an audit of outcomes in patients with metastatic renal cancer suitable for treatment with tyrosine kinase inhibitors. Clinical Oncology, 21 (8). pp. 610-616. doi:10.1016/j.clon.2009.06.007 ISSN 0936-6555.
Sydes, Matthew R., Parmar, Mahesh K. B., James, Nicholas D., Clarke, Noel W., Dearnaley, David P., Mason, Malcolm D., Morgan, Rachel C., Sanders, Karen and Royston, Patrick (2009) Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer : the MRC STAMPEDE trial. Trials, 10 (1). 39. doi:10.1186/1745-6215-10-39 ISSN 1745-6215.
Sternberg, C. N., Petrylak, D. P., Sartor, O., Witjes, J. A., Demkow, T., Ferrero, J.-M., Eymard, J.-C., Falcon, S., Calabro, F., James, Nicholas D., Bodrogi, I., Harper, P., Wirth, M., Berry, W., Petrone, M. E., McKearn, T. J., Noursalehi, M., George, M. and Rozencweig, M. (2009) Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy : the SPARC trial. Journal of Clinical Oncology, 27 (32). pp. 5431-5438. doi:10.1200/JCO.2008.20.1228 ISSN 0732-183X.
Ansari, Jawaher, Fatima, Arfeen, Chaudhri, Shalini, Bhatt, Rupesh I., Wallace, Michael and James, Nicholas D. (2009) Sorafenib induces therapeutic response in a patient with metastatic collecting duct carcinoma of kidney. Onkologie , 32 (1-2). pp. 44-46. doi:10.1159/000183736 ISSN 0378-584X.
James, Nicholas D., Sydes, Matthew R., Clarke, Noel W., Mason, Malcolm D., Dearnaley, David P., Anderson, John, Popert, Richard J., Sanders, Karen, Morgan, Rachel C., Stansfeld, Jim, Dwyer, John, Masters, John and Parmar, Mahesh K. B. (2009) Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial. BJU International, 103 (4). pp. 464-469. doi:10.1111/j.1464-410X.2008.08034.x ISSN 1464-1603.
Cruickshank, G. S., Ngoga, D., Detta, A., Green, S., James, Nicholas D., Wojnecki, C., Doran, J., Hardie, J., Chester, M., Graham, N. et al.
(2009)
A cancer research UK pharmacokinetic study of BPA-mannitol in patients with high grade glioma to optimise uptake parameters for clinical trials of BNCT.
Applied Radiation and Isotopes, 67
(7-8).
S31-S33.
doi:10.1016/j.apradiso.2009.03.016
ISSN 0969-8043.
Patel, Prashant, Young, J Graham, Mautner, Vivien, Ashdown, Daniel, Bonney, Sarah, Pineda, Robert G., Collins, Stuart I., Searle, Peter F, Hull, Diana, Peers, Elizabeth, Chester, John, Wallace, D Michael, Doherty, Alan, Leung, Hing, Young, Lawrence S. and James, Nicholas D. (2009) A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1984. Molecular Therapy, 17 (7). pp. 1292-1299. doi:10.1038/mt.2009.80 ISSN 1525-0016.
Young, J. G., Green, N. K., Mautner, V., Searle, P. F., Young, Lawrence S. and James, Nicholas D. (2008) Combining gene and immunotherapy for prostate cancer. Prostate Cancer and Prostatic Diseases, Vol.11 (No.2). pp. 187-193. doi:10.1038/sj.pcan.4501008 ISSN 1365-7852.
Fitzpatrick, John M., Anderson, John, Sternberg, Cora N., Fleshner, Neil, Fizazi, Karim, RΓ©billard, Xavier, Dogliotti, Luigi, Conti, Giario, Turesson, Ingela, James, Nicholas D. et al.
(2008)
Optimizing treatment for men with advanced prostate cancer : expert recommendations and the multidisciplinary approach.
Critical Reviews in Oncology/Hematology, 68
(1).
S9-S22.
doi:10.1016/j.critrevonc.2008.07.019
ISSN 1040-8428.
James, Nicholas D., Sydes, Matthew R., Clarke, Noel W., Mason, Malcolm D., Dearnaley, David P., Anderson, J., Popert, Richard J., Sanders, K., Morgan, Rachel C., Stansfeld, J., Dwyer, John, Masters, J. and Parmar, Mahesh K. B. (2008) STAMPEDE : systemic therapy for advancing or metastatic prostate cancer - a multi-arm multi-stage randomised controlled trial. Clinical Oncology, 20 (8). pp. 577-581. doi:10.1016/j.clon.2008.07.002 ISSN 0936-6555.
Parmar, Mahesh K. B., Barthel, F. M.- S., Sydes, Matthew R., Langley, R., Kaplan, R., Eisenhauer, E., Brady, M., James, Nicholas D., Bookman, M. A., Swart, A.-M., Qian, W. and Royston, P. (2008) Speeding up the evaluation of new agents in cancer. JNCI Journal of the National Cancer Institute, 100 (17). pp. 1204-1214. doi:10.1093/jnci/djn267 ISSN 0027-8874.
Sikora, K. and James, Nicholas D. (2008) Top-up payments in cancer care. Clinical Oncology, 21 (1). doi:10.1016/j.clon.2008.11.002 ISSN 0936-6555.
James, Nicholas D., Williams, M. V., Summers, E. T., Jones, K. and Cottier, B. (2008) The management of interruptions to radiotherapy in head and neck cancer : an audit of the effectiveness of national guidelines. Clinical Oncology, 20 (8). pp. 599-605. doi:10.1016/j.clon.2008.05.003 ISSN 0936-6555.
This list was generated on Tue Apr 23 07:11:01 2024 BST.